Skip to main content

Table 2 Eligibility criteria

From: Development of a multicomponent implementation strategy to reduce upper gastrointestinal bleeding risk in patients using warfarin and antiplatelet therapy, and protocol for a pragmatic multilevel randomized factorial pilot implementation trial

Patient eligibility criteria

Inclusion:

• Enrollment with the Michigan Medicine anticoagulation monitoring service

• Currently prescribed warfarin with anticipated use for ≥90 days on day 1 of trial enrollment, according to the EHR medication list

• Currently prescribed an antiplatelet drug (aspirin, clopidogrel, ticagrelor, or prasugrel) according to the EHR medication list

Exclusion:

• Age less than 18

• Prescribed a Proton pump inhibitor

• Documented intolerance or allergy to Proton pump inhibitor use

• Left ventricular assist device

• Heart transplant

Clinician eligibility criteria

Inclusion:

• Practicing cardiologists at Michigan Medicine who in the prior year had a face-to-face or virtual visit with a patient who meets eligibility criteria for this study

• Practicing clinicians in any specialty who are designated as the clinician of record with the anticoagulation clinic for a patient who meets eligibility criteria

Exclusion:

• Cardiologists specializing in electrophysiology who are not the designated clinician of record for at least one patient meeting eligibility criteria

  1. EHR electronic health record